Company Filing History:
Years Active: 2005-2020
Title: The Innovations of Stephen Smith
Introduction
Stephen Smith is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the field of biotechnology, particularly in the development of human antibodies. With a total of six patents to his name, his work has had a considerable impact on therapeutic methods.
Latest Patents
Among his latest patents are innovations related to human antibodies against eotaxin. These patents include specific binding members directed to eotaxin-1, particularly human antibodies and antibody fragments that neutralize eotaxin-1 activity. His patents detail the antibodies VH and/or VL domain of the scFv fragment termed CAT-212 and the IgG4 antibody termed CAT-213. They also describe methods of obtaining specific binding members that bind eotaxin, as well as compositions containing these members for therapeutic use.
Career Highlights
Stephen has worked with prominent companies in the biotechnology sector, including Medimmune Limited and Cambridge Antibody Technology Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in antibody development.
Collaborations
Stephen has collaborated with notable coworkers such as Tristan J Vaughan and Alison Jane Wilton. These partnerships have further enhanced his research and innovation capabilities.
Conclusion
Stephen Smith's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence therapeutic methods and advancements in medical science.